10x Genomics, Inc. (TXG) bonds
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)
Close on Nov 17, 2026Market cap $7.34BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
10x Genomics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in 10x Genomics's 10-K for the period ended Dec 31, 2022
10x Genomics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Letter of Credit | $7.50M |
See a number that looks wrong?